Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion ...

Walgreens Boots Alliance (WBA) announced that at the Company’s Special Meeting of Shareholders, WBA shareholders approved the previously announced acquisition of the Company by entities affiliated ...

The deal, announced on March 6, would allow Sycamore Partners to take Walgreens private. The drug-store chain expects the transaction to close in the third or fourth quarter of 2025.

Walgreens Boots Alliance shareholders gave the thumbs up to the private-equity buyout by Sycamore Partners, with about 96% of ...

Walgreens' journey from public to private ownership is set to begin, with shareholders giving their blessing to a ...

Store closures and weak front-of-store comps led to a retail sales decline in Q3, but U.S. pharmacy and international sales ...

The term "special situations" covers a lot of ground on Wall Street. In the case of Walgreens, the situation that is special ...

Walgreens' results beat Wall Street expectations, based on a survey of analysts by LSEG. The company reported adjusted earnings per share of 38 cents, exceeding the analyst consensus of 34 cents.

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the "Company" or "WBA") today announced that at the Company’s Special Meeting of Shareholders (the "Special Meeting"), WBA shareholders approved the ...

Walgreens' $10B sale to Sycamore Partners ends a long decline for one of Chicago’s most iconic companies — and raises questions about what comes next.

The buyout, which will take the drugstore chain private for the first time in nearly a century, will give it more flexibility ...